|1.||Secrest, Charles L: 2 articles (04/2006 - 12/2003)|
|2.||Madjar, Shahar: 2 articles (04/2006 - 12/2003)|
|3.||Smith, S: 1 article (10/2013)|
|4.||Draganic, B: 1 article (10/2013)|
|5.||Morris, O J: 1 article (10/2013)|
|6.||Nahas, William C: 1 article (03/2011)|
|7.||Falci, Renato: 1 article (03/2011)|
|8.||Piovesan, Affonso C: 1 article (03/2011)|
|9.||Saito, Fernando J A: 1 article (03/2011)|
|10.||Kanashiro, Hideki: 1 article (03/2011)|
|2.||Stress Urinary Incontinence
04/01/2006 - "Durasphere is gaining popularity as a bulking agent for treating women with stress urinary incontinence. "
07/01/2003 - "Durasphere is a urethral bulking agent used to treat stress urinary incontinence secondary to intrinsic sphincter deficiency. "
07/01/2001 - "A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere."
10/01/2002 - "METHODS.: Fifty-two women diagnosed with stress urinary incontinence caused by ISD were treated between March and November of 1998 in a randomized, double-blinded trial comparing Durasphere and Contigen. "
03/01/2004 - "The durability of Durasphere (Carbon Medical Technologies, Saint Paul, Minnesota), used to treat stress urinary incontinence, has not been shown beyond 12 months of followup. "
|3.||Gastroesophageal Reflux (GERD)
02/01/2009 - "A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial."
02/01/2009 - "Durasphere appears to be a promising new injectable bulking agent for the treatment of mild-moderate GERD, with demonstrable efficacy and no significant adverse events in a small cohort."
02/01/2009 - "Our purpose was to assess the long-term safety and effectiveness of Durasphere (Carbon Medical Technologies, St Paul, Minn), a new injectable bulking agent, in the treatment of mild-moderate GERD. "
04/01/2008 - "Two patients complained of moderate anal pain for a few days after the implant, one patient had asymptomatic leakage of the injected material through a mucosa perforation, and two had distal migration of the Durasphere along the dentate line. "
05/01/2009 - "In the Durasphere group, complications included rectal pain (5%), erosion through rectal mucosa (10%), and type III hypersensitivity reaction (5%). "
|3.||Transplantation (Transplant Recipients)